Randomized Controlled Trial of Home Therapy With Caffeine Citrate in Moderately Preterm Infants With Apnea of Prematurity

Trial Profile

Randomized Controlled Trial of Home Therapy With Caffeine Citrate in Moderately Preterm Infants With Apnea of Prematurity

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2018

At a glance

  • Drugs Caffeine (Primary) ; Caffeine (Primary)
  • Indications Apnoea
  • Focus Therapeutic Use
  • Acronyms MoCHA
  • Most Recent Events

    • 06 Apr 2018 Planned End Date changed from 1 Mar 2022 to 1 Jun 2022.
    • 06 Apr 2018 Planned primary completion date changed from 1 Mar 2022 to 1 Jun 2022.
    • 06 Apr 2018 Planned initiation date changed from 1 Jan 2018 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top